Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Elliptic Laboratories A stock

ELABS.OL
NO0010722283
A2QFQQ

Price

12.84
Today +/-
+0.00
Today %
+0.31 %
P

Elliptic Laboratories A stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Elliptic Laboratories A stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Elliptic Laboratories A stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Elliptic Laboratories A stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Elliptic Laboratories A's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Elliptic Laboratories A Stock Price History

DateElliptic Laboratories A Price
10/3/202412.84 undefined
10/2/202412.80 undefined
10/1/202412.90 undefined
9/30/202413.38 undefined
9/27/202412.78 undefined
9/26/202412.52 undefined
9/25/202412.98 undefined
9/24/202412.86 undefined
9/23/202413.10 undefined
9/20/202413.08 undefined
9/19/202413.28 undefined
9/18/202412.78 undefined
9/17/202413.02 undefined
9/16/202413.14 undefined
9/13/202413.62 undefined
9/12/202413.32 undefined
9/11/202414.00 undefined
9/10/202413.64 undefined
9/9/202414.36 undefined
9/6/202414.40 undefined
9/5/202412.22 undefined

Elliptic Laboratories A Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Elliptic Laboratories A, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Elliptic Laboratories A from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Elliptic Laboratories A’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Elliptic Laboratories A. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Elliptic Laboratories A’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Elliptic Laboratories A’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Elliptic Laboratories A’s growth potential.

Elliptic Laboratories A Revenue, EBIT and net profit per share

DateElliptic Laboratories A RevenueElliptic Laboratories A EBITElliptic Laboratories A Net Income
2026e506.76 M undefined245.14 M undefined177.83 M undefined
2025e352.26 M undefined162.74 M undefined121.45 M undefined
2024e154.5 M undefined20.6 M undefined21.69 M undefined
202368.32 M undefined-47.98 M undefined-38 M undefined
202252.06 M undefined-40.77 M undefined-33 M undefined
202154.6 M undefined-9.58 M undefined-11.21 M undefined
202030.22 M undefined-7.52 M undefined-12.51 M undefined
201937.96 M undefined-12.6 M undefined-13.26 M undefined
201841.58 M undefined-32.04 M undefined-28.12 M undefined
201710.69 M undefined-42.91 M undefined-34.25 M undefined

Elliptic Laboratories A Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024e2025e2026e
10413730545268154352506
-310.00-9.76-18.9280.00-3.7030.77126.47128.5743.75
90.00100.00--------
94100000000
-42-32-12-7-9-40-4720162245
-420.00-78.05-32.43-23.33-16.67-76.92-69.1212.9946.0248.42
-34-28-13-12-11-32-3821121177
--17.65-53.57-7.69-8.33190.9118.75-155.26476.1946.28
84.7285.6485.8489.2598.33103.97104.32000
----------
Details

Keystats

ⓘ

Revenue and Growth

The Elliptic Laboratories A Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Elliptic Laboratories A is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2017201820192020202120222023
             
34.8314.0732.7498.57216.83176.44112.77
3.1214.7714.310.4329.0340.560.61
6.445.626.7317.817.76.846.36
0000000
3.072.8524.811.41.845.9
47.4637.3155.79121.6264.95225.62185.64
007.265.022.792.2619.91
0000000
1.062.133.64.054.525.048.86
3.229.8516.5528.2436.5647.5757.81
0000000
46.752.9556.1759.8162.5468.8477.69
50.9864.9383.5897.12106.41123.71164.27
98.45102.24139.37218.72371.36349.32349.91
             
0.860.860.880.961.041.041.05
2.56.2170.64174.64342.55345.51355
0000000
68.5140.338.5112.5-0.81-20.93-48.94
0000000
71.8647.480.03188.1342.77325.62307.11
1.12.530.830.993.031.673.86
5.877.197.646.228.429.3313.08
1.622.120.170.2000
0000000
443.0131.486.26.616.187.99
12.5954.8440.1313.6218.0617.1824.93
14019.211710.536.5217.87
0000000
0000000
14019.211710.536.5217.87
26.5954.8459.3430.6228.5923.742.8
98.45102.24139.37218.72371.36349.32349.91
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Elliptic Laboratories A provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Elliptic Laboratories A's financial health and stability.

Assets

Elliptic Laboratories A's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Elliptic Laboratories A must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Elliptic Laboratories A after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Elliptic Laboratories A's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
-43-33-16-15-13-39-46
124581116
0000000
0-7,000-1,000-2,000-17,0001,000-17,000
2325101310
1122000
0000000
-38-35-11-6-10-12-37
-1-8-9-15-17-23-25
-1-8-9-15-17-23-25
0000000
0000000
-225-1-27-6-6-7
5004312516229
46233887146-40
-1.00-1.00-2.00-10.00-9.00--
0000000
6-201765118-39-62
-40.24-43.9-20.65-21.78-28.43-36.09-63.75
0000000

Elliptic Laboratories A stock margins

The Elliptic Laboratories A margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Elliptic Laboratories A. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Elliptic Laboratories A.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Elliptic Laboratories A's sales revenue. A higher gross margin percentage indicates that the Elliptic Laboratories A retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Elliptic Laboratories A's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Elliptic Laboratories A's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Elliptic Laboratories A's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Elliptic Laboratories A. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Elliptic Laboratories A's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Elliptic Laboratories A Margin History

Elliptic Laboratories A Gross marginElliptic Laboratories A Profit marginElliptic Laboratories A EBIT marginElliptic Laboratories A Profit margin
2026e100 %48.37 %35.09 %
2025e100 %46.2 %34.48 %
2024e100 %13.33 %14.04 %
2023100 %-70.23 %-55.62 %
2022100 %-78.31 %-63.38 %
2021100 %-17.54 %-20.54 %
2020100 %-24.88 %-41.4 %
2019100 %-33.18 %-34.93 %
2018100 %-77.06 %-67.63 %
201787.85 %-401.22 %-320.24 %

Elliptic Laboratories A Stock Sales Revenue, EBIT, Earnings per Share

The Elliptic Laboratories A earnings per share therefore indicates how much revenue Elliptic Laboratories A has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Elliptic Laboratories A earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Elliptic Laboratories A's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Elliptic Laboratories A’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Elliptic Laboratories A's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Elliptic Laboratories A Revenue, EBIT and net profit per share

DateElliptic Laboratories A Sales per ShareElliptic Laboratories A EBIT per shareElliptic Laboratories A Earnings per Share
2026e4.81 undefined0 undefined1.69 undefined
2025e3.35 undefined0 undefined1.15 undefined
2024e1.47 undefined0 undefined0.21 undefined
20230.65 undefined-0.46 undefined-0.36 undefined
20220.5 undefined-0.39 undefined-0.32 undefined
20210.56 undefined-0.1 undefined-0.11 undefined
20200.34 undefined-0.08 undefined-0.14 undefined
20190.44 undefined-0.15 undefined-0.15 undefined
20180.49 undefined-0.37 undefined-0.33 undefined
20170.13 undefined-0.51 undefined-0.4 undefined

Elliptic Laboratories A business model

Elliptic Laboratories A is one of the most popular companies on Eulerpool.com.

Elliptic Laboratories A Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Elliptic Laboratories A historical P/E ratio, EBIT multiple, and P/S ratio

Elliptic Laboratories A shares outstanding

The number of shares was Elliptic Laboratories A in 2023 — This indicates how many shares 104.317 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Elliptic Laboratories A earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Elliptic Laboratories A's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Elliptic Laboratories A’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Elliptic Laboratories A's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Elliptic Laboratories A stock splits

In Elliptic Laboratories A's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Elliptic Laboratories A.

Elliptic Laboratories A latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.05 0.04  (-22.33 %)2024 Q2
3/31/2024-0.1 -0.02  (80.58 %)2024 Q1
12/31/20230.1 -0.19  (-284.47 %)2023 Q4
9/30/2023-0.1 -0.07  (32.04 %)2023 Q3
6/30/20230 0.04  (0 %)2023 Q2
3/31/2023-0.1 -0.14  (-35.92 %)2023 Q1
12/31/2022-0.1 -0.18  (-74.76 %)2022 Q4
9/30/20220 0.06  (0 %)2022 Q3
6/30/2022-0.1 -0.06  (41.75 %)2022 Q2
3/31/2022-0.1 -0.14  (-35.92 %)2022 Q1
1
2

Elliptic Laboratories A shareholders

%
Name
Stocks
Change
Date
8.45207 % MP Pensjon8,897,91301/30/2024
8.44776 % DNB Asset Management AS8,893,3753,658,4211/30/2024
7.03237 % Alden AS7,403,33001/30/2024
5.76682 % Handelsbanken Kapitalförvaltning AB6,071,024328,8371/30/2024
4.77640 % Robert (Horne)5,028,35001/30/2024
4.15498 % Danielsen (Laila Beate)4,374,15001/30/2024
3.38756 % Vinterstua AS3,566,252-292,3981/30/2024
2.67870 % Larne Overseas Ltd.2,820,00001/30/2024
12.15909 % Passesta AS12,800,48001/30/2024
1.42484 % Fondsfinans Kapitalforvaltning AS1,500,000713,9762/29/2024
1
2
3

Elliptic Laboratories A Executives and Management Board

Mr. Svenn-Tore Larsen64
Elliptic Laboratories A Independent Chairman of the Board
Compensation 100,000
Mr. Edvin Austbo
Elliptic Laboratories A Director
Compensation 100,000
Ms. Berit Svendsen60
Elliptic Laboratories A Independent Director
Compensation 100,000
Ms. Laila Danielsen
Elliptic Laboratories A President, Chief Executive Officer
Mr. Lars Holmoy
Elliptic Laboratories A Chief Financial Officer
1
2

Most common questions regarding Elliptic Laboratories A

What is the P/E ratio of Elliptic Laboratories A 2024?

The Elliptic Laboratories A P/E ratio is 61.76.

What is the P/S ratio of Elliptic Laboratories A 2024?

The Elliptic Laboratories A P/S ratio is 8.67.

What is the AlleAktien quality score of Elliptic Laboratories A?

The AlleAktien quality score for Elliptic Laboratories A is 4/10.

What is the revenue of Elliptic Laboratories A 2024?

The expected Elliptic Laboratories A revenue is 154.5 M NOK.

How high is the profit of Elliptic Laboratories A 2024?

The expected Elliptic Laboratories A profit is 21.69 M NOK.

What is the business model of Elliptic Laboratories A

No history available for Elliptic Laboratories A.

What is the Elliptic Laboratories A dividend?

Elliptic Laboratories A pays a dividend of 0 NOK distributed over payouts per year.

How often does Elliptic Laboratories A pay dividends?

The dividend cannot currently be calculated for Elliptic Laboratories A or the company does not pay out a dividend.

What is the Elliptic Laboratories A ISIN?

The ISIN of Elliptic Laboratories A is NO0010722283.

What is the Elliptic Laboratories A WKN?

The WKN of Elliptic Laboratories A is A2QFQQ.

What is the Elliptic Laboratories A ticker?

The ticker of Elliptic Laboratories A is ELABS.OL.

How much dividend does Elliptic Laboratories A pay?

Over the past 12 months, Elliptic Laboratories A paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Elliptic Laboratories A is expected to pay a dividend of 0 NOK.

What is the dividend yield of Elliptic Laboratories A?

The current dividend yield of Elliptic Laboratories A is .

When does Elliptic Laboratories A pay dividends?

Elliptic Laboratories A pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Elliptic Laboratories A?

Elliptic Laboratories A paid dividends every year for the past 0 years.

What is the dividend of Elliptic Laboratories A?

For the upcoming 12 months, dividends amounting to 0 NOK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Elliptic Laboratories A located?

Elliptic Laboratories A is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Elliptic Laboratories A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Elliptic Laboratories A from 10/4/2024 amounting to 0 NOK, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Elliptic Laboratories A pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Elliptic Laboratories A in the year 2023?

In the year 2023, Elliptic Laboratories A distributed 0 NOK as dividends.

In which currency does Elliptic Laboratories A pay out the dividend?

The dividends of Elliptic Laboratories A are distributed in NOK.

All fundamentals about Elliptic Laboratories A

Our stock analysis for Elliptic Laboratories A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elliptic Laboratories A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.